Idera Pharmaceuticals, Inc. (IDRA) financial statements (2021 and earlier)

Company profile

Business Address 505 EAGLEVIEW BOULEVARD
EXTON, PA 19341
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3843711131096041
Cash and cash equivalents334071113812720
Short-term investments43  283421
Other undisclosed cash, cash equivalents, and short-term investments(0)0     
Other undisclosed current assets4314231
Total current assets:4146731171116342
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment0001221
Long-term investments and receivables     277
Long-term investments     277
Regulated entity, other noncurrent assets    000
Restricted cash and investments   000 
Other undisclosed noncurrent assets0000000
Total noncurrent assets:11022299
TOTAL ASSETS:4247731181139251
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6899858
Accounts payable0011112
Accrued liabilities6788744
Employee-related liabilities      1
Debt 0 0000
Derivative instruments and hedges, liabilities 46     
Deferred revenue and credits111 
Other liabilities0      
Other undisclosed current liabilities0     (1)
Total current liabilities:755910977
Noncurrent Liabilities
Long-term debt and lease obligation11  011
Long-term debt, excluding current maturities    011
Operating lease, liability11
Liabilities, other than long-term debt119 01010
Deferred revenue and credits 01 
Other liabilities  01000
Derivative instruments and hedges, liabilities119      
Other undisclosed noncurrent liabilities73     
Total noncurrent liabilities:127401121
Total liabilities:134599111098
Stockholders' equity
Stockholders' equity attributable to parent(91)(11)641081038443
Common stock0000000
Additional paid in capital742710728712642584495
Accumulated other comprehensive loss    (0)(0)(0)
Accumulated deficit(834)(721)(664)(604)(538)(500)(452)
Total stockholders' equity:(91)(11)641081038443
TOTAL LIABILITIES AND EQUITY:4247731181139251

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net11600
Gross profit: 1111600
Operating expenses(37)(48)(62)(67)(55)(49)(39)
Operating loss:(37)(46)(61)(66)(39)(49)(39)
Nonoperating income0111000
Investment income, nonoperating0111000
Foreign currency transaction gain (loss), before tax(0)(0)(0)(0)000
Interest and debt expense(0) (0)(0)(0)  
Loss before gain (loss) on sale of properties:(37)(45)(60)(66)(38)(48)(39)
Other undisclosed net loss(76)(12)     
Net loss:(113)(57)(60)(66)(38)(48)(39)
Other undisclosed net loss attributable to parent     (0) 
Net loss attributable to parent:(113)(57)(60)(66)(38)(49)(39)
Preferred stock dividends and other adjustments (28)    (1)
Net loss available to common stockholders, diluted:(113)(85)(60)(66)(38)(49)(39)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(113)(57)(60)(66)(38)(48)(39)
Comprehensive loss:(113)(57)(60)(66)(38)(48)(39)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   00(0)(0)
Comprehensive loss, net of tax, attributable to parent:(113)(57)(60)(66)(38)(49)(39)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: